Skip to main content

Around the League

Presented By

Seahawks GM: Bruce Irvin's suspension 'disappointing'

Coach Pete Carroll and the Seattle Seahawks took some criticism in Seattle over the weekend for the team's problem with player suspensions for performance-enhancing drug use.

Debate: NFL's best receiving corps?


Is there any group of pass-catchers that can top Julio Jones and Co. in Atlanta? Our analysts discuss the elite of the elite. **More ...**

Though outspoken on many issues, Carroll hasn't said much about his team's PED problems. But Seahawks general manager John Schneider started to tackle the issue Monday during a segment on SiriusXM NFL Radio, via ESPN's Mike Sando.

Schneider said defensive end Bruce Irvin's four-game suspension "obviously needs to be addressed" and is a learning situation for the team. Irvin's suspension was especially "disappointing" to Schneider because he said the team has gone "above and beyond what the league has done" to educate players about PEDs.

Schneider's comments seem to indicate the team understands PED use has become a growing problem in Seattle. Schneider said Carroll spoke with the team privately about Irvin's suspension.

The Seahawks have had more PED suspensions than any other team in the NFL since Carroll took over.

UPDATE: Carroll spoke to reporters after Monday's practice and said he'll re-evaluate his PED policy, according to KJR-FM's Elise Woodward. "It's not right yet," Carroll said. "We have to figure it out through education, or finding other ways."

Carroll also said they are not turning their back on Irvin. "We're going to help him as best we possibly can," he said. "He's made a tremendous commitment to try to do the right things and try to be right. He made a mistake. He admitted to it. He owned up to it to his teammates, he owned up to it to the staff and to everybody."

Follow Gregg Rosenthal on Twitter @greggrosenthal.

This article has been reproduced in a new format and may be missing content or contain faulty links. Please use the Contact Us link in our site footer to report an issue.

Related Content